Eicosanoids metabolized through LOX distinguish asthma–COPD overlap from COPD by metabolomics study

BACKGROUND AND OBJECTIVE: The prevalence of asthma is greater than 20% in patients previously diagnosed with COPD. Patients with asthma–COPD overlap (ACO) are at risk of rapid progression of disease and severe exacerbations. However, in some patients with ACO, a clear distinction from COPD is very d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chuanxu, Bian, Xiqing, Xue, Mingshan, Liu, Xiaoqing, Hu, Haisheng, Wang, Jingxian, Zheng, Song Guo, Sun, Baoqing, Wu, Jian-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689553/
https://www.ncbi.nlm.nih.gov/pubmed/31496676
http://dx.doi.org/10.2147/COPD.S207023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689553/
https://www.ncbi.nlm.nih.gov/pubmed/31496676
http://dx.doi.org/10.2147/COPD.S207023

Ejemplares similares